Status:

COMPLETED

Lab School Day Study for CONCERTA of Older Children With ADHD

Lead Sponsor:

Ortho-McNeil Janssen Scientific Affairs, LLC

Conditions:

Attention Deficit Hyperactivity Disorder

Eligibility:

All Genders

9-12 years

Phase:

PHASE4

Brief Summary

The purpose of this trial is to determine if the study medication, CONCERTA (methylphenidate HCl), is safe and effective in improving academic performance and behavior in children with attention defic...

Detailed Description

The hypothesis is that CONCERTA (methylphenidate HCl) is safe and effective in improving academic performance and behavior in children with ADHD, when compared to placebo as demonstrated using specifi...

Eligibility Criteria

Inclusion

  • ADHD diagnosis of all subtypes (except Not Otherwise Specified)
  • Patients with total or subscale Attention Deficit Hyperactivity Disorder Rating Scale (ADHD RS-IV) scores \> =90th percentile relative to the general population of children by age and gender
  • Patients currently receiving ADHD medication must be inadequately managed on their current stimulant dose and meet this criteria at the screening visit
  • Ability to read and understand English
  • Ability to attend school regularly.

Exclusion

  • Estimated Full Scale IQ score of 80 or below
  • Severe Learning Disability
  • History of, or current, primary diagnosis of: severe anxiety disorder, conduct disorder, psychotic disorders, pervasive developmental disorder, eating disorder, obsessive-compulsive disorder, sleep disorder, major depressive disorder, bipolar disorder, substance use disorder, chronic tic disorder, personal or family history of Tourette's syndrome
  • Weight \< 3rd percentile for age
  • History of hospitalization for treatment of a mood, anxiety, or psychotic disorder
  • History of failed response to methylphenidate.

Key Trial Info

Start Date :

December 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2009

Estimated Enrollment :

78 Patients enrolled

Trial Details

Trial ID

NCT00799409

Start Date

December 1 2008

End Date

June 1 2009

Last Update

May 9 2014

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Irvine, California, United States

2

Houston, Texas, United States